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Background: Clostridium difficile is an anaerobic, Gram-positive bacterium that can reside as a commensal within
the intestinal microbiota of healthy individuals or cause life-threatening antibiotic-associated diarrhea in
immunocompromised hosts. C. difficile can also form highly resistant spores that are excreted facilitating host-to-host
transmission. The C. difficile spo0A gene encodes a highly conserved transcriptional regulator of sporulation that is
required for relapsing disease and transmission in mice.
Results: Here we describe a genome-wide approach using a combined transcriptomic and proteomic analysis to
identify Spo0A regulated genes. Our results validate Spo0A as a positive regulator of putative and novel sporulation
genes as well as components of the mature spore proteome. We also show that Spo0A regulates a number of
virulence-associated factors such as flagella and metabolic pathways including glucose fermentation leading to
butyrate production.
Conclusions: The C. difficile spo0A gene is a global transcriptional regulator that controls diverse sporulation, virulence
and metabolic phenotypes coordinating pathogen adaptation to a wide range of host interactions. Additionally, the
rich breadth of functional data allowed us to significantly update the annotation of the C. difficile 630 reference
genome which will facilitate basic and applied research on this emerging pathogen.
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Genome annotationBackground
Clostridium difficile has emerged over the past decade to
become the most common cause of infectious antibiotic-
associated diarrhea within healthcare systems worldwide
[1]. This Gram-positive, anaerobic bacterium commonly
resides asymptomatically in healthy individuals who can
serve as a transmission reservoir within a hospital setting
[2]. The emergence of C. difficile virulence is linked to
the acquisition of multiple resistance determinants to
commonly used antibiotics [3-6] allowing this pathogen
to thrive in the intestines of patients following antibiotic* Correspondence: tl2@sanger.ac.uk
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unless otherwise stated.treatment [7]. C. difficile can produce a number of potent
virulence-associated factors that contribute to intestinal
colonization and disease [8], and facilitate the establish-
ment of a pathological imbalance within the resident
microbiota [9]. Unlike many other healthcare pathogens,
C. difficile produces highly resistant and transmissible spores
and, as a consequence, creates significant challenges to
infection control and environmental decontamination
protocols [10].
Sporulation is a complex developmental program leading
to the generation of metabolically dormant spores from
vegetative cells [11]. Spo0A is a transcription factor that is
active in the early stages of sporulation in C. difficile and
other sporulating bacteria [12]. Orthologues of Spo0A
are encoded by a variety of the Firmicutes [13], including
Bacillus and Clostridium, and the genetic inactivation oftd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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In the well studied Clostridium and Bacillus organisms,
many of the pleiotropic effects of Spo0A are due to indirect
regulation via the transition state regulator AbrB [16-20].
However, C. difficile does not encode an AbrB orthologue
highlighting differences in Spo0A activity between C. diffi-
cile and other Clostridium and Bacillus species studied
to date [5,21]. C. difficile Spo0A binds directly to DNA
upstream of several early sporulation genes [21] but this
transcriptional regulator may also control other processes
not obviously associated with sporulation. For example, in
C. difficile Spo0A has also been implicated in controlling
toxin gene expression [22] and disease in mice [15,23] and
biofilm formation in vitro [24,25].
Consequently, we performed a genome-wide analysis
to define Spo0A regulated genes within C. difficile using
a combined transcriptomic and proteomic approach. Our
analysis demonstrates that the C. difficile spo0A gene en-
codes a global transcriptional regulator that coordinates
an array of phenotypes associated with host colonization
and transmission. The rich breadth of our functional data
allowed us to make significant updates to the annotation
of the C. difficile 630 reference genome.
Results
C. difficile growth dynamics in vitro
We and others [14,15,23] have previously demonstrated
that C. difficile 630Δerm produces spores and that an iso-
genic spo0A::ermB mutant does not, but that sporulation
can be restored by expressing the spo0A gene in trans
[23]. Here we confirm this phenotype in Wilson’s broth
supplemented with glucose [26] and show that C. difficile
630Δerm and the spo0A mutant displayed comparable
growth kinetics under these culture conditions with shaking
(Figure 1a) which allows for more reproducible growth
compared to cultures grown statically [27]. Interestingly,a)
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Figure 1 Growth and sporulation kinetics of C. difficile 630 derivative
parental strain and its spo0A isogenic mutant. Shown are the OD600 measu
the right y-axis. The gray vertical arrow indicates that sampling point. b) W
exponential and stationary growth stages by the parental C. difficile 630Δerm
purified protein as described before [21].we found that the sporulation program was active primar-
ily during exponential phase, leading to an increase in the
formation of ethanol resistant spores at the transition into
stationary growth phase. We observed no discernable
increase in spores during stationary phase (Figure 1a).
During mid-exponential stage approximately 1 in 100,000
cells (103 spores/ml) and during late-exponential approxi-
mately 1 in 3,000 cells (105 spores/ml) were ethanol-resistant
spores (Figure 1a). The growth conditions used in our
study are not optimized for sporulation, as we wished to
obtain a broad picture of Spo0A dependent transcriptional
effects, rather than identifying the Spo0A-dependent sporu-
lation program. As a result, the observed spore levels are
lower than achieved with other growth conditions [27-29].
Western blot analysis using C. difficile Spo0A-specific
antibodies demonstrated that Spo0A was produced during
both exponential and stationary growth by C. difficile
630Δerm but not a spo0A mutant derivative (Figure 1b).
Given our interest in defining the genes controlled by C.
difficile Spo0A and the potential links between sporula-
tion and other phenotypes we chose to focus on mid-
exponentially growing C. difficile (vertical gray arrow in
Figure 1a) for subsequent experiments.
Functional enrichment of the C. difficile 630 genome
annotation with transcriptomics and proteomics
To survey and compare the global transcriptomes of C.
difficile 630Δerm and the spo0A mutant we performed
high-density, strand-specific cDNA sequencing (RNAseq)
of RNA extracted from exponentially growing cultures
and mapped the sequence data to the C. difficile 630 gen-
ome [5,30]. Next we normalised the mean abundance of
reads per gene (Additional file 1) and identified 321 genes
that were differentially expressed (P-adjusted value < 0.01)
in the spo0A mutant, of which 164 were upregulated and
157 were downregulated compared to C. difficile 630Δermexponential stationary
191
97
64
51
39
28
19
6
3
63
0
Δs
po
0A
63
0
Δs
po
0A
Pu
rif
ie
d 
Sp
o
0A
kDa
b)
28
100
102
104
106
108
1010
spores/m
l
s in broth cultures. a) Growth curves of the C. difficile 630Δerm
rements on the left y-axis and ethanol-resistant spore-derived CFUs on
estern blot analysis demonstrating that Spo0A is expressed under
strain but not the isogenic spo0A mutant. Spo0A-his6 protein was
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by Spo0A (either positively or negatively) were evenly
distributed around the genome and were encoded on
both the forward and reverse strands (data not shown).
We also performed comparative proteomic analysis on
the same C. difficile cultures to complement the RNAseq
dataset. Proteins were extracted from the same samples
used for RNA analysis and separated on SDS-PAGE
followed by in-gel digestion and peptide extraction. To
compare protein levels, the generated peptides were labeled
with dimethyl stable isotope labels and mixed prior to
mass spectrometry analysis. Peptide identification and
quantitation were assigned using MaxQuant software.
Using a 1% false discovery rate (FDR) we identified
polypeptide products corresponding to 1000 genes. Not-
ably, the proteomic analysis showed better coverage for
abundant proteins and a higher proportion of cytoplasmic
compared to membrane or secreted proteins (Additional
file 2). We found 123 proteins that were differentially
regulated by a log2 fold change, of which 75 proteins
were decreased and 48 increased in relative abundance
in the spo0A mutant derivative compared to C. difficile
630Δerm. A strong correlation was observed (Figure 2)
between the transcriptomic and proteomic datasets. A
detailed break down of each dataset into function class as
well as the intersection of the trancriptomic and prote-
omic analysis datasets are given as a searchable excel file
in Additional file 2.-3 -2 -1 1
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Figure 2 Correlation between transcriptomic and proteomic datasets
compared to the parental C. difficile 630Δerm strain. The degree of cor
been quantified in both proteome (y-axis) and RNASeq (x-axis) analyses. Sig
with red/brown (upregulated) and light green/dark green (downregulated)
least two biological replicates are depicted as significant (dark colours). See
without being upregulated at the transcript level (“proteome up”).Our combined transcriptomic and proteomic dataset
comparing the 630Δerm and the spo0A mutant derivatives
provided a unique opportunity to enrich the current
genome annotation of the reference C. difficile 630, par-
ticularly for those genes that were previously annotated
as “conserved hypothetical” based on in silico predictions
[5,30]. This study represents the largest functional analysis
of the reference C. difficile 630 genome since its creation
in 2006 [5] and builds upon previous annotation updates
[30] by validation of the implicated genes that is not
possible by in silico methods.
The improved annotation described here is primarily
based on the presence of differentially expressed genes in
the RNAseq and proteomic datasets (this study) or the
mature spore proteome [27] datasets (Additional file 2).
For those genes implicated in the experimental dataset
that did not have a known functional product, in silico
annotation was undertaken to predict a function. This
utilised searches on nucleotide and amino acid sequences
of homologous genes and prediction of protein family and
domain sites with the Pfam database [31] and Prosite
database [32] in addition to identifying subcellular local-
isation of proteins using SignalP [33] and THMMM [34].
This process was also complemented by literature searches
relating to the functional characterisation of the genes and
their products in question. A feature of any annotated
genome is that it is current only at the time it was created.
In light of this in silico annotation as described above was2 3 4 5
transciptome (log2 fold change)
proteome and transcriptome up
transcriptome up
proteome and transcriptome down
transcriptome down
proteome and transcriptome unchanged
proteome down
of genes differentially expressed in the C. difficile spo0A mutant
relation are plotted as log2 fold change for all gene products that had
nificantly (p-adj < 0.01) disregulated proteins or transcripts are shown
symbols. Protein groups that were positive in Significance B test of at
methods for analysis details. Note that no proteins were upregulated
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were not present in the experimental dataset.
The initial annotation of the C. difficile 630 genome
characterised genes by functional classes adapted from
the Riley class system [35] (Additional file 2). For brevity
some classes have been collapsed into broader functional
descriptions. The number of genes in most functional
classes has increased since that original annotation [5]
(Figure 3). The notable exceptions are the classes ‘fatty
acid biosynthesis’ (class 3.6.0), a decrease of 1, and ‘cell
envelope’ (class 4.0.0), a decrease of 138. Genes previously
in class 4.0.0 have now transferred to a wide range of
different functional classes including ‘cell processes’ (class
1.0.0), ‘sporulation’ (class 1.8.1), ‘extrachromosomal’ (class
5.0.0) and ‘conserved hypothetical’ (class 0.0.2) reflecting
transitions between functional classes based on more
accurate annotation tools and increasing numbers of
C. difficile genomic studies.
Correspondingly the functional classes characterising
genes of an unknown or a putative function i.e. ‘hypothet-
ical’ (class 0.0.0), ‘conserved hypothetical’ (class 0.0.2) and
‘uncharacterised’ (class 7.0.0), have all decreased in number
except for class 0.0.2. However 92 of these genes were not
identified in the initial 2006 annotation (Figure 3) and a
further 133 were initially part of class 0.0.0 and have been
moved to class 0.0.2 representing annotation studies onhy
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Figure 3 Updated functional class annotation of C. difficile 630 genom
classified according to functional classes for the original 2006 annotation (b
described in more detail in Additional file 2.subsequent C. difficile strains. As a result, there are
now only 3 genes in class 0.0.0 (CD2933, CD2947A
and CD3148).
In total 662 genes were differentially expressed in the
spo0A RNAseq, spo0A proteome or the mature spore
proteome datasets representing 17% of the entire C.
difficile 630 gene content. 11 of the 662 differentially
expressed genes that previously were classified as 0.0.2
or 7.0.0 now have a known function, these include 4
spore coat associated genes: CD1433 (cotE), CD1511 (cotB),
CD1567 (cotG) and CD1613 (cotA) [36,37]. The presence
of 68 genes in the experimental dataset that previously
resided in class 0.0.2 are now updated to class 7.0.0 con-
firming their expression. Interestingly, 6 genes that were
previously classified as pseudogenes due to the presence
of frameshifts or mobile genetic elements have been
changed to functioning genes based on their presence in
the experimental dataset. 2 of these (CD0816 and CD1718)
are interrupted by IStrons. The ability of the IStron to be
excised from the mRNA transcript and not interfere with
gene functionality [38,39] is corroborated by the presence
of these genes in the experimental dataset.
In silico annotation of genes in classes 0.0.0, 0.0.2 and
7.0.0 that were not present in the experimental dataset
also resulted in considerable improvements to the elucida-
tion of gene products. 24 genes previously contained in0)
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classification of 9 more genes has improved from class
0.0.2 to class 7.0.0. In addition to this a further 5 genes
(CD0606, CD1499, CD1570, CD1820 and CD2553), previ-
ously classified as pseudogenes due to been interrupted by
IStrons have been restored to functional genes. All of
these improvements are representative of a broad range of
functional classes.
Now 3409 out of the 3897 genes in the C. difficile 630
genome have either a known or putative function or
experimental evidence confirming the gene is expressed.
Other significant improvements to the annotation include
the re-classification of sigK (CD1230) as a functional gene;
the presence of the skin prophage-like element which in-
terrupts the gene is not detrimental to gene functionality
due to controlled excision [40].
In addition to identifying gene products, gene nomen-
clatures have been updated where possible. Gene nomen-
clatures for 26 of the cell wall proteins (cwp) [41] have
been added as well as the cationic peptide resistance cluster
cprA,B,C and its regulators cprR and cprK [42,43]. Gene
names for the extra cytoplasmic sigma factors csfU,V,T and
the associated anti-sigma factors rsiU,V,T which are in-
volved in sensing and responding to extracellular
stresses [44] have also been added. Finally, duplicate gene
names have been resolved where appropriate by the
addition of a number or letter.
The annotation has been updated on the main gen-
omic sequence repositories (accession no. AM180355)
and the embl file can also be accessed at http://www.
sanger.ac.uk/resources/downloads/bacteria/clostridium-
difficile.html which contains all of the functional class
annotations described here. Subsequent analysis in this
manuscript was performed using the newly annotated
C. difficile 630 genome.
Genome-wide functional classification of the Spo0A
regulated genes
The differentially expressed genes identified by tran-
scriptomics and proteomics were assigned into functional
classes based on a modified version of the Riley system
[5,35] (Figure 4). Our analysis indicated that Spo0A regu-
lates genes representing a broad array of functional classes
(Additional file 2), although there was an enrichment of
certain classes (Figure 4a and b). For example, of the 96
genes in the sporulation/germination functional class, 25
genes were positively regulated by Spo0A, that is, their
expression was attenuated in the spo0A mutant, whereas
no genes in this class were relatively upregulated (Figure 4a
and b). Gene classes comparatively downregulated in the
spo0A mutant include those assigned to the functional clas-
ses transport/binding (20), metabolism (24), cell-envelope
architecture (20) and gene regulation (19) (Figure 4a). In
contrast, genes linked to the functional classes chemotaxis/mobility (15), transport/binding (28), metabolism (45),
cell-envelope architecture (20) and gene regulation (18)
were upregulated in the spo0A mutant relative to the par-
ental strain (Figure 4b).
Several genes that were previously shown to harbor a
consensus Spo0A binding site upstream of their coding
sequences [21] were differentially regulated in the spo0A
mutant at the transcript or protein level. For instance,
Spo0A binds to the upstream region of ssuA, which
shows significantly lower RNA and protein levels in the
spo0A mutant compared to wild type (Additional file 2).
Similarly, the putative direct target lplA shows increased
levels of RNA and protein. Thus, these genes are likely
direct targets of Spo0A in C. difficile. We found that many
genes with altered transcript levels do not contain a con-
sensus Spo0A binding motif [21]. These may either reflect
regulation through a non-consensus Spo0A-binding motif,
or indirect regulation. It is noteworthy that several putative
transcriptional regulators show changes in transcript levels
(Additional file 3) and strong Spo0A dependent regulation
without the presence of a clear Spo0A binding site has pre-
viously been noted for Clostridium acetobutylicum [45].
Overall, these data indicate the C. difficile Spo0A directly
and indirectly regulates a diverse set of genes potentially
linked to different phenotypes beyond sporulation.
Spo0A positively regulates the sporulation cascade
Our analysis of the C. difficile Spo0A-asssociated sporula-
tion pathway was guided by an abundance of knowledge
available for the sporulation pathway in B. subtilis [46]. C.
difficile 630 encodes a number of orthologues for genes
such as CodY, SinR and ScoC that regulate the earliest
stages of sporulation in B. subtilis upstream of Spo0A.
Neither codY nor scoC genes are under the control of
Spo0A (Figure 5). However, the sinR gene was upregulated
in the C. difficile spo0A mutant, indicating negative
regulation by Spo0A, similar to B. subtilis [47] (Additional
file 2). C. difficile 630 does not harbour orthologues of the
Spo0A phosphorelay proteins of B. subtilis that lead to
Spo0A phosphorylation. However, others have suggested
that one or more orphan histidine kinases of C. difficile
can directly or indirectly affect Spo0A activation [15] and
two of these genes encoding potential kinases, CD1492 and
CD1579, are differentially expressed in the spo0A mutant
versus wild type cells (Figure 5) (Additional file 2).
Phosphorylation of Spo0A leads to the activation of a
sigma factor cascade that acts in both mother cell and
forespore (Figure 5) and many of the early stage B. subtilis
sporulation proteins are highly conserved in C. difficile
630 genome, including the sporulation specific sigma
factors SigH, SigF, SigG, SigE, SigA2 and SigK [11]. We
found that Spo0A influenced the expression of the sigE,
sigG, sigF and sigA2 genes that were relatively under
represented in the spo0A mutant. Taken together, these
downregulated in Δspo0A
upregulated in Δspo0A
RNAseq
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Figure 4 Functional classification of C. difficile Spo0A regulated genes. Enriched functional gene classes of genes (a) downregulated or
(b) upregulated in the C. difficile spo0A mutant. The number of genes present in each functional class based on RNAseq (grey) and proteomics
(black) analysis. The combined RNAseq and proteomics (red) represents unique genes found in each functional class. Transcripts and proteins
assigned to functional classes are given in parenthesis and are based on the updated C. difficile 630 annotation presented in this study
(Additional file 2).
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http://www.biomedcentral.com/1471-2164/15/160data suggest that in C. difficile Spo0A positively controls
the expression of SigF, SigG, SigA2 and SigE during the
early stages of sporulation (Figure 5).
Our data indicates that the role of Spo0A in regulating
the formation of endospores is relatively conserved between
B. subtilis and C. difficile. However, based on genomic and
proteomic comparisons the later stages (cortex, coat and
release; stages IV and V: reviewed in [11]) of sporulation
appear to be less conserved. We found the three transcrip-
tional units encoding early sporulation genes previouslypredicted to be direct targets of Spo0A in C. difficile [21],
spoIIAA-AB-AC/sigF, spoIIGA-sigG-sigE and spoIIE, were
under represented in the spo0A mutant. The list of signifi-
cantly affected genes also includes SigE-dependent genes,
such as spoIIID and the spoIIIAA-AH operon. Of all of
these stage II and III genes in the Spo0A regulon, only
SigG is found in the mature spore (Additional file 2).
It should be noted that our analysis did not identify
many of the conserved later-stage IV and V genes [11] as
differentially expressed in the spo0A mutant, likely due
Figure 5 Proposed sporulation cascade for Clostridium difficile 630. Names of genes and proteins are derived from updated genome
annotation (Additional file 2). Solid arrows in the putative regulatory cascade of C. difficile indicate confirmed interactions [15,21], whereas dotted
arrows indicate uncharacterized or postulated interactions. Operon structure or genomic region of (conserved) sporulation genes is given when
relevant, and in vitro confirmed Spo0A binding sites are indicated with vertical blue bars. Genes are roughly aligned with the stage of sporulation
at which they act, except for C. difficile sporulation genes that are not conserved in B. subtilis. When gene names start with spo, this has been
omitted for clarity. CD3673 encodes a protein with high similarity to Spo0J. CD0125 encodes a protein with homology to B. subtilis spoIIQ.
spoIV encodes a homolog of the B. subtilis YqfD protein. sigK is known as spoIIIC (N-terminal part) and spoIVCB (C-terminal part) in B. subtilis and is
interrupted by a skin element. CD1231 encodes the recombinase in skin and is annotated as spoIVCA in B. subtilis. oxaA1 is known as spoIIIJ in B.
subtilis. pth is known as spoVC in B. subtilis. spoVE is an FtsW-like protein and is sometimes annotated as such in C. difficile. The product of ftsH2 is
the closest homolog of SpoVK of B. subtilis. C. difficile 630 encodes several SpoIIIE/FtsK like proteins. If and which one is associated with sporulation is
unknown. cotF/cotCB and cotJB2/cotD are homologs of the B. subtilis genes cotJB and cotJC. SleB is also known as PrsW [44]. CspBA is a serine protease.
Proteins from this family in B. subtilis are not directly identified as sporulation specific. CspC is a germination receptor [48]. sipL was hypothesized to
encode a functional substitute for B. subtilis SpoVID [49]. CD1613 (cotA), CD1511 (cotB), CD1433 (cotE), CD1567 (cotG) have been given a cot alias in a
recent study [37]. For the genes in grey the identification as homologs of the B. subtilis sporulation gene is tentative. Green colors indicate upregulated
and red colors indicate downregulated in a spo0A mutant compared to the parental C. difficile 630Δerm strain at the transcriptome or proteome level
in this study. Recently, the transcription of many genes - including most of the genes from this scheme - was identified as dependent on sporulation
specific sigma factors [28,29,50].
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http://www.biomedcentral.com/1471-2164/15/160to the growth conditions. Many of these are controlled
by the late sporulation sigma factor SigK, and consistent
with this we observed no effect of a spo0A mutation on
sigK transcription under our experimental conditions.
The exceptions are spoIVA, spoVD, cspBA-cspC and sipL
which are under control of SigE [51]. We also identified
the genes encoding the subtilisin like protease CspBA [52],
the germinant receptor CspC [48], and the spore morpho-
genetic protein SipL [49] as differentially expressed in the
spo0A mutant.Spo0A regulates colonization and virulence genes
Our analysis revealed that distinct functional classes
linked to C. difficile virulence and colonization are under
control of Spo0A. Consistent with our previous studies
[23], the toxin gene tcdA was significantly upregulated
in the C. difficile spo0A mutant (Additional file 2). We
could not identify a consensus ‘0A’ binding box upstream
of the tcdA start site and in vitro binding assays did not
indicate that tcdA was a direct target of Spo0A [21]. Thus,
Spo0A appears to indirectly control tcdA gene expression,
Pettit et al. BMC Genomics 2014, 15:160 Page 8 of 15
http://www.biomedcentral.com/1471-2164/15/160perhaps via one of the many other factors that control
toxin gene expression [53-56]. Our analyses were carried
out on cells in exponential growth phase, where toxin
expression is lower compared to stationary growth phase
[57]. This may in part explain the fact that the tcdB gene
(which is expressed at much lower levels than tcdA
[56,58] was not identified as differentially expressed.
Our data suggests that Spo0A exerts significant control
over the C. difficile cell envelope architecture and associ-
ated structures (Figure 4a and b), several of which are im-
plicated in intestinal adherence, colonisation or subversion
of the hosts’ immune system. For example, six genes en-
coding surface proteins showed altered transcription in
the spo0A mutant; cwp10, CD2797 and CD3246 are up-
regulated in the spo0A mutant whereas cwp19, cwp27 and
cwp29 are all downregulated. Two of these, CD2797 and
CD3246 possess adherence-associated domains while the
remaining four (cwp10, cwp19, cwp27 and cwp29) encode
members of the cell wall protein family [41]. Several genes
implicated in remodeling of the cell wall are also regulated
by Spo0A. For example, uppS1 encodes an undecaprenyl-
pryophosphate synthase responsible for synthesizing a cell
wall carbohydrate lipid precursor, and is downregulated
in the spo0A mutant. Two genes in the dlt alanylation
operon, dltA and dltB, were significantly upregulated in
the spo0A mutant. These later two genes are located
within a four-gene operon involved in the esterification
of teichoic acid or lipoteichoic acid with D-alanine, con-
ferring resistance to cationic antimicrobial peptides [59].
In C. difficile 630, components of the flagellar assembly
apparatus are encoded by two loci that are divided by an
inter-flagellar locus that has been implicated in flagellin
glycosylation. Fourteen genes encoding flagellar proteins
(fliC, fliE, fliF, fliG, fliH, fliI, fliJ, fliK, fliW, fliZ, flbD,
flgB, flgD and motB) and the four transcripts (CD0241-
CD0244) that constitute the inter-flagellar glycosylation
locus [60] were relatively upregulated in the spo0A mu-
tant at the mRNA level (Additional file 2). However, the
differences in expression of the flagella structural genes
were not reflected in the proteomic data and this is
likely due to loss of the flagella from bacterial cells during
sample preparation.
We could not identify a consensus Spo0A binding
motifs immediately upstream of the Spo0A-affected cell
membrane/wall associated genes, with the exception of
putative CD0241-0244 operon [21]. This indicates that the
majority of the effects of Spo0A on this class of genes are
either mediated by degenerate motifs or indirectly via one
or more of the Spo0A-affected transcriptional regulators
(Additional file 3).
To validate these observations we examined C. difficile
630Δerm and the isogenic spo0A mutant for the presence
of peritrichous flagella by negative staining and TEM.
We consistently observed no cell-anchored flagella onthe parental C. difficile 630Δerm (Figure 6a). However, the
spo0A mutant displayed a striking hyper-flagellate pheno-
type with an average of 8.1 flagella/bacterium (n = 210;
average length 8.8 μm and average diameter 15.2 nm)
(Figure 6b). Complementation with a plasmid-borne copy
of spo0A partially restored the phenotype and reduced the
average number of flagella to 4.3 per bacterium (n = 240;
average length 3.5 μm and average diameter 14.6 nm)
(Figure 6c). Together these results demonstrate a role
of Spo0A in negatively controlling C. difficile flagella
production.
C. difficile Spo0A is a positive regulator of butyrate
biosynthesis
Spo0A positively regulates several regulatory genes pre-
dicted to be involved in carbohydrate uptake and metabol-
ism (Additional file 2). For example, 3 separate bglG-type
genes involved in carbohydrate sensing and transcriptional
anti-termination are downregulated in a spo0A mutant,
and 7 transcriptional regulators are downregulated in the
spo0A mutant, most of which are predicted to respond to
nutrients and extracellular cues (Additional file 2). Further,
several membrane-associated transporters of the phospho-
transferase system (PTS) with predicted specificity for
beta-glucoside (bglF-type) are downregulated in the spo0A
mutant (Figure 7a and Additional file 2). Key genes from
the glycolysis pathway that convert glucose to pyruvate
were downregulated in the spo0A mutant, including the
glucose-6-phosphate isomerase (pgi), the central glycolytic
genes regulator (cggR) and putative 6-phospho-alpha- and
beta-glucosidases (bglA4 and bglA7, respectively).
Glucose fermentation can lead to the production of a
variety of metabolic by-products including butyrate
(glucose is the only carbohydrate in the growth medium).
Interestingly, we found that the entire butyrate production
operon [61] was downregulated in the C. difficile spo0A
mutant at both the mRNA and protein levels (Additional
file 2), including butyryl-CoA dehydrogenase (bcd2),
electron transfer flavoprotein β-subunit (etfB3), electron
transfer flavoprotein α-subunit (etfA3), 3-hydroxybutyryl-
CoA dehydratase (crt2), 3-hydroxybutyryl-CoA dehydro-
genase (hbd) and acetyl-CoA acetyltransferase (thlA1).
Figure 7 illustrates a proposed biochemical pathway for
glucose uptake and fermentation highlighting in red those
genes under positive control of Spo0A. Key components
of this butyrate production pathway are also present in
the C. difficile 630 spore proteome [27], suggesting a pos-
sible association between butyrate and spore formation
and/or germination in C. difficile. None of the genes listed
above harbor a consensus Spo0A binding site in their
immediate upstream region. Interestingly, ptb and buk,
encoding a phosphate butyryltransferase and a butyrate
kinase, respectively, were upregulated in the spo0A mutant
at the mRNA level. These two genes are potentially
630ΔermB Δspo0A Δspo0A
+pspo0A
a b c
Figure 6 Spo0A is a negative regulator of C. difficile flagellar synthesis. Representative transmission electron micrographs of negatively
stained C. difficile 630Δerm and derivatives demonstrating a) no observable flagella on the parental 630Δerm strain but b) hyper-flagellation in the
spo0A mutant derivative. Genetic complementation of the c) spo0A mutation greatly reduced flagella levels but did not eliminate their production.
Scale bar represents 1 micron.
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ptb contains a Spo0A box [21] and the buk gene likely
forms an operon with ptb.
To determine which of these transcriptional responses
dominates the butyrate biosynthetic pathway we measured
butyrate from exponentially growing C. difficile 630Δerm
and the spo0A mutant. We found that the C. difficile
spo0A mutant produced significantly less butyrate than
the parental 630Δerm (P = 0.0005; Figure 7). Moreover,
the spo0A mutant complemented in trans with a plasmid
borne spo0A gene produced levels of butyrate that were
statistically comparable with the 630Δerm parental strain
(P = 0.6; Figure 7). Thus, overall C. difficile Spo0A posi-
tively controls butyrate production, likely via an indirect
mechanism.
Discussion
C. difficile Spo0A is generally considered a transcriptional
regulator of sporulation although recent reports have
suggested additional roles in toxin gene regulation in vitro
[15,23] and intestinal colonization and disease in mice
[23]. Here we demonstrate an unappreciated role for
C. difficile Spo0A as a global transcriptional regulator
of colonization, virulence, sporulation and metabolic
phenotypes. Thus, Spo0A influences all aspects of the
C. difficile infection cycle allowing the bacterium to
adapt to changing environments experienced during
infection and host-transmission. The wide array of pheno-
typic defects in the C. difficile spo0A mutant would explain
our previous results demonstrating that the C. difficile
spo0A gene is required for persistent colonization and
disease in mice [23].
Spo0A is a transcriptional regulator that is activated via
phosphorylation from a cognate membrane-associated
sensor histidine kinase(s) in response to an environmental
cue(s). Underwood et al. [15] demonstrated that the histi-
dine kinase CD2492 can potentially serve as a phosphoryl-
ation donor for C. difficile Spo0A and proposed that other
histidine kinases (i.e. CD1492 and CD1579) may alsointeract with Spo0A suggesting multiple environmental
inputs. The environmental cues that lead to C. difficile
Spo0A phosphorylation remain unknown but we predict
such cues to be mainly present within the mammalian
intestinal tract when C. difficile is metabolically active.
Further, we propose such environmental cues influence
an array of physiological states and phenotypes during
the complete C. difficile lifecycle since Spo0A is present in
the mature spore [27] and during all stages of vegetative
growth [21].
C. difficile sporulation in the laboratory seems to occur
asynchronously [28,49,50]. Though our sampling timepoint
likely covers multiple growth stages, we cannot exclude
the possibility that specific early or late timepoint-specific
effects of Spo0A are missed in our analyses. Indeed, as a
result of our choice of timepoint, late sporulation genes
are underrepresented in our study. However, several stud-
ies have specifically addressed the role of Spo0A and
the downstream sporulation specific sigma factors in
the sporulation program [28,29,50]. Our genome and
proteome analysis provides an excellent starting point
to discriminate genes under direct or indirect control
of Spo0A in C. difficile. We find that Spo0A affects the
expression of several regulators (Additional file 3), suggest-
ing that many of the observed effects may be indirect.
Future research will focus on defining those environ-
mental cues and associated histidine kinases that lead to
Spo0A phosphorylation and the downstream genes that
are under direct control of Spo0A-P to delineate the C.
difficile Spo0A regulon.
Our study defined Spo0A-dependent gene expression
patterns and phenotypes that allow us to speculate on C.
difficile’s lifestyle within the intestinal tract. For example,
Spo0A negatively regulates the sporulation cascade and
surface proteins proposed to promote host interactions
(i.e. CD2797 and CD3246) in addition to negatively
regulating virulence factor expression (flagella and Toxin A).
Perhaps during sporulation C. difficile downregulates
some virulence and motility functions to avoid host
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Figure 7 Spo0A positively regulates glucose fermentation pathways and butyrate production in C. difficile. a) Proposed biochemical
pathway for glucose uptake and fermentation leading to the production of butyrate. Genes in red are downregulated in the C. difficile spo0A
mutant and genes in green are upregulated in the C. difficile spo0A mutant. Genes in black are not impacted by the spo0A mutation. b) Levels of
butyrate from supernatants of C. difficile strains during exponential growth. Analysis was performed in triplicate and levels compared using a
Student’s T test; **, P = 0.0005; *, P = 0.6.
Pettit et al. BMC Genomics 2014, 15:160 Page 11 of 15
http://www.biomedcentral.com/1471-2164/15/160surveillance while adhering to the mucosal surface. Indeed,
we routinely observe C. difficile sporulating on the mucosal
surface within the murine intestinal tract [62,63]. Spo0A
also coordinates shifts in nutrient transporters and meta-
bolic pathways perhaps in response to the available nutri-
ents on the mucosal surface such as complex and simple
carbohydrates within the mucus layer overlying the intes-
tinal epithelial cells [64]. Spo0A also positively regulates
butyrate production, a significant energy source for intes-
tinal epithelial cells [65], potentially representing a meta-
bolic link between C. difficile and the host to promote
mucosal adherence. It is of note that several of the
genes and programs identified in our study were also
found to be Spo0A dependent in C. acetobutylicum [45,66],
suggesting that these are conserved and physiologically
relevant patterns.
Even though we linked C. difficile Spo0A to distinct
physiological states and phenotypes the vast majority of
genes misregulated in a C. difficile spo0A mutant are of
putative or hypothetical function due to the lack of know-
ledge about C. difficile biology and host interactions. The
rich breadth of transcriptome and proteome data provided
a unique opportunity to perform a significant functional
annotation to the C. difficile 630 reference genome. With
the recent description of genetic mutagenesis methods
[14,52] and murine infection models [62,67,68] the updated
genome annotation will facilitate studies into C. difficile
colonization, disease and transmission.
Conclusions
The C. difficile spo0A gene is a global transcriptional
regulator that controls diverse sporulation, virulence and
metabolic phenotypes coordinating pathogen adaptation
to a wide range of host interactions. Additionally, the rich
breadth of functional data allowed us to significantly update
the annotation of the C. difficile 630 reference genome
which will facilitate basic and applied research on this
emerging pathogen.
Methods
Bacterial strains and growth conditions
C. difficile strains 630Δerm, 630Δerm spo0A::ermB (named
the spo0A mutant in this manuscript) and 630Δerm
spo0A::ermB + pspo0A were previously described [23]. C.
difficile was grown at 37°C under anaerobic conditions in
a MACS MG-500 anaerobic workstation (Don Whitley
Scientific). C. difficile was routinely cultured in Wilson’sbroth plus 1% glucose with agitation (80 rpm) or on
CCEY agar (Bioconnections) supplemented with cycloser-
ine (250 μg/ml; Bioconnections), cefoxitin (8 μg/ml; Bio-
connections) and 0.1% taurocholate (Sigma Aldrich) for
24 to 48 hours. For the enumeration of spores, C. difficile
cultures were mixed with 100% ethanol (1:1 ratio) for 1 h at
room temperature to kill vegetative cells, pelleted, washed
in PBS and cultured as above.
Western blotting
Proteins resolved by SDS-PAGE were electrophoretically
transferred to a nitrocellulose membrane at 30 V for 1 h.
Protein transfer was visualised by staining in Ponseau-S
Red (Sigma Aldrich) for 2 min, and membranes were
blocked in blocking buffer (5% milk powder in 0.1%
PBS-T) for 1 h at room temperature. Membranes were
then probed with a Spo0A primary antibody (1/10,000)
[21] overnight at 4°C, washed, and detected with an ap-
propriate HRP-conjugated secondary antibody (1/10,000)
for 1 h at room temperature. Proteins were revealed by
chemiluminescence detection according to the Amersham
ECL system (GE Healthcare), as per the manufacturer’s
instructions.
RNA preparation and cDNA synthesis
Total RNA isolation and cDNA synthesis was performed as
previously described [69]. Briefly, three biological replicates
of C. difficile culture (~1010 total cells) from exponentially
growing cells were harvested in RNAProtect (Qiagen)
according to the manufacturer’s protocol. Total RNA
was extracted by chemical and mechanical lysis using a
FastRNA Pro Blue Kit (MP Biomedicals) and FastPrep
ribolyser, according to the manufacturer’s recommenda-
tions. Total RNA was purified using the SV RNA Isolation
Purification Kit (Promega) according to the manufacturer’s
instructions. Genomic DNA was removed from total RNA
samples using one treatment of Turbo DNase (Ambion)
according to the manufacturer’s recommendations. RNA
quantification and integrity was determined using both a
ND-1000 (NanoDrop Technologies) and 2100 Bioanalyser
(Agilent Technologies). Samples were screened for the
presence of genomic DNA using primer pairs CD1498
F: GATTGCAGATGCATGTGGTT and CD1498 R: T
TGGAGAGCAAGAACAGCAA, CD1455 F: GATGCAG
AGGCAATTTCACA and CD1455 R: GCTAGAAGGATG
CACGAAGG, CD0011F: CCAGCTTTGCAACACCAAC
T and CD0011 R: GGCTATGGAGGCTTCTTATGG, and
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AGCCTTAGGAAGTGGAAA. Equal amounts of DNA-
free RNA (5 μg) was reverse transcribed to complemen-
tary DNA (cDNA) as follows. 20 μg RNA was incubated
with 3 μg random hexamers and RNaseOUT ribonuclease
inhibitor in a total volume of 16.4 μl, at 70°C for 10 min
and then cooled on ice. For cDNA synthesis, 6 μl First
Strand buffer, 0.6 μl dNTP mix (25 mM each dATP, dCTP,
dGTP, dATP), 0.4 μl actinomycin D (1.2 mg/ml), 3 μl
DTT (0.1 M) and 2 μl Superscript III were added to a total
volume of 33 μl. Second strand cDNA synthesis was not
performed in order to retain the strand specific sequence
determination [70]. Samples were then incubated for 2 h
at 42°C, following which RNA was hydrolysed with 1.5 μl
NaOH (1 M) for 20 min at 70°C. Finally, samples were
neutralised with 1.5 μl HCl (1 M) and cDNA was purified
using a G50-Sephadex column (Sigma-Aldrich), according
to manufacturer’s instructions. Samples were screened for
the presence of cDNA using specific primer pairs (above).
Library construction and sequencing
Libraries were constructed by shearing the purified cDNA
using a Covaris LE220 focused ultrasonicator to give frag-
ments in the range of 150–250 bp. This was followed by an
end-repair incubation with T4 DNA polymerase, Klenow
polymerase and T4 polynucleotide kinase (to phosphorylate
blunt-ended fragments) for 30 min at 20°C. cDNA samples
were then 3′ adenosine-tailed via the addition of Klenow
exo- and dATP for 30 min at 37°C to reduce concatameri-
sation. Illumina adaptors (containing complementary sites
to oligonucleotide anchors on the flow cell surface and
primer sites for sequencing) were then ligated onto the
cDNA repaired ends, and ligated fragments were electro-
phoretically separated from any unligated adapters based
on size-selection. Fragments were then isolated via gel
extraction. Libraries were amplified via PCR (18 cycles),
quantified and denatured with 2 M NaOH to generate
single stranded cDNA for sequencing. Samples were then
loaded onto an Illumina flow cell to which the samples
hybridise to the lawn of complementary oligonucleotide
primers. Flow cell primers were then extended for 75
sequencing cycles, ultimately yielding clusters of clonally
amplified cDNA templates. All steps were performed
according to the manufacturer’s recommendations.
RNASeq analysis
Transcripts were mapped using SMALT (http://www.
sanger.ac.uk/resources/software/smalt/). Differential ex-
pression analysis was performed using R version 3.0.0 and
DESeq statistical analysis package [71]. For comparison
with proteomic data, moderated log-fold changes were
calculated using the variance stabilizing transformation
supplied by Deseq. P-values were corrected for multiple
testing using the Benjamini–Hochberg method, and aq-value threshold of 0.01 was used to identify differentially
regulated genes with an expected false discovery rate of
10% (see Additional file 1).
Protein extraction and in-gel digestion
Three biological replicates of C. difficile 630 wild-type, C.
difficile 630Δerm and C. difficile 630ΔermΔspo0A cultures
were prepared. Briefly, ~1010 cells from exponentially
growing C. difficile were harvested by centrifugation,
resuspended in 300 μl lysis buffer (8 M urea, 2 M thiourea,
4% sodium dodecyl sulphate (SDS), 20 mM tris(2-carbox-
yethyl)phosphine (TCEP) in PBS) and incubated at 70°C
for 10 min. Cells were then mechanically disrupted using
acid-washed glass beads (size 425–600 μm; Sigma Aldrich)
and a FastPrep ribolyser. The lysate supernatant was
collected and clarified by centrifugation at 14,000 rpm
for 30 min. Finally, samples were alkylated with a final con-
centration of 5 mM idoacetamide (IAA; Sigma-Aldrich).
Samples with an equivalency to ~2 × 107 cells were loaded
to a 12% Bis-Tris NuPAGE gel (Invitrogen) for protein
separation. 18 bands were excised from each sample lane
followed by in-gel digestion with trypsin in 50 mM TEAB.
Peptides were extracted by 50% acetonitrile/0.5% formic
acid and dried in a SpeedVac. For one of the biological
replicate, three technical replicates from the SDS-PAGE
step were prepared such that were five replicates in total
for proteomic analysis.
Peptide dimethyl labelling and LC-MS/MS analysis
The dried peptides were derivatized with dimethyl triplex
with cross-labelling using the standard in-solution protocol
by Boersema [72], i.e. all primary amine (the N-terminus
and the side chain of lysine residues) were converted to
dimethylamines through reaction with formaldehyde (light),
formaldehyde-D2 (intermediate) or formaldehyde-13C-D2
(heavy) and cyanoborohydride (light and intermediate) or
cyanoborodeuteride (heavy).
The differentially labelled samples were mixed corres-
pondingly before the nanoLC-MS/MS analysis on a LTQ
Orbitrap Velos (Thermo Fisher) hybrid mass spectrometer
equipped with a nanospray source, coupled with an Ultim-
ate 3000 RSLCnano System (Dionex). The system was con-
trolled by Xcalibur 2.1 (Thermo Fisher) and DCMSLink
2.08 (Dionex). Only 1/3 of total volume of each sample
was submitted to analysis. Samples were first loaded and
desalted on a PepMap C18 trap (0.3 mm id × 5 mm, 5 μm,
Dionex) at 10 μL/min for 15 min, then peptides were
separated on a 75 μm id × 50 cm PepMap RSLC column
(Dionex, 2 μm) over a 120 min linear gradient of 4–32%
CH3CN/0.1% FA at a flow rate at 300 nL/min. The LTQ
Orbitrap Velos was operated in the “Top 10” data-
dependant acquisition mode. The 10 most abundant and
multiply-charged precursor ions in the MS survey scan in
the Orbitrap (m/z 400 – 1500, with the lock mass at
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duced dissociation fragmentation (MS/MS) in the LTQ
Velos ion trap. The ions must have a minimal signal
above 2000 counts. The preview mode of FT master
scan was disabled. The Orbitrap resolution was set at
60,000 at m/z 400 with one microscans. The isolation
width for the precursor ion was set at 2 Th. The normal-
ized collision energy was set at 35% with activation Q at
0.250 and activation time for 10 msec. The dynamic exclu-
sion mass width was set at ±20 ppm and exclusion duration
for 60 seconds. To achieve high mass accuracy, the AGC
(Automatic Gain Control) were set at 1 × 106 for the full
MS survey in the Orbitrap with a maximum injection time
at 100 msec, and 5000 for the MS/MS in the LTQ Velos
with a maximum injection time at 300 msec.
Protein identification and quantification
The raw files were processed with MaxQuant Software
(version 1.3.0.5, http://maxquant.org) for protein identifi-
cation and quantification. The Andromeda search engine
was used to search the MS/MS spectra using the following
parameters: trypsin/P with maximum 2 missed cleavages
sites; peptide mass tolerance at first search was set at
20 ppm; MS/MS fragment mass tolerance at 0.49 Da, and
top 6 MS/MS peaks per 100 Da and a minimum peptide
length of 6 amino acids were required. The mass accuracy
of the precursor ions was improved by the time-dependent
recalibration algorithm of MaxQuant. Fixed modification
for Carbamidomethyl and variable modifications for
Deamidated (NQ) and Oxidation (M) were used, and a
maximum of three labelled amino acids per peptide
were allowed. The protein databases were extracted
from annotated genome databases of C. difficile 630 (June
2013), and the contaminant database was supplemented
by MaxQuant.
False discovery rates (FDR) were estimated based on
matches to reversed sequences in the concatenated target-
decoy database, and an FDR threshold of 1% was used for
proteins and peptides. Peptides were assigned to protein
groups, a cluster of a leading protein(s) plus additional
proteins matching to a subset of the same peptides. Protein
groups with posterior error probability (PEP) values over
0.01 or matches to reversed database or contaminants were
discarded. Protein identification was reported for protein
groups with at least one unique peptide.
MaxQuant normalized protein ratios of the C. difficile
spo0A mutant over the parental C. difficile 630Δerm strain
were converted to Log2 values. For each sample with three
technical replicates, the Log2 protein ratio used was derived
from the mean value of three repeat analyses. The final
Log2 protein ratios reported represents the mean values
of three biological replicates, and only values with at least
three ratio counts were used. The protein group ratios from
three biological replicates were also analyzed in Perseus(version 1.3.0.4), using the Significance B method which
considered both the protein ratio and intensities of the pep-
tide ions. Protein groups that were positive in Significance
B tests of at least two biological replicates are reported as
significant.
Transmission electron microscopy
Grids were prepared by briefly submerging slides into
Formvar (0.1%) in dry chloroform. Formvar-carbon-coated
support films were then floated onto distilled water, after
which grids were placed onto the film before lifting onto
parafilm and air-drying. Fresh bacterial colonies were
picked, suspended in ammonium acetate and loaded onto
the film side of the grid. An equal volume of ammonium
molybdate (1%) was added to the film and immediately
drained with filter paper. Samples were allowed to air-dry
and were visualised via TEM as described above.
Butyrate measurements
Culture supernatants of exponentially growing C. difficile
630Δerm strains were acidified, converted to t-butyldi-
methylsilyl derivatives as previously described and quan-
tified by capillary gas chromatography [73]. Butyrate
quantification was performed in triplicate.
Availability of supporting data
The updated annotation for Clostridium difficile 630
described in this study is available in the main genomic se-
quence repositories under the accession number AM180355
(http://www.ebi.ac.uk/ena/data/view/am180355) and at
http://www.sanger.ac.uk/resources/downloads/bacteria/
clostridium-difficile.html. Fastq files from RNAseq ana-
lysis are available in ArrayExpress under the accession
number E-ERAD-97 (http://www.ebi.ac.uk/arrayexpress/ex-
periments/E-ERAD-97/).
Additional files
Additional file 1: Identification of differentially expressed genes in
C. difficile 630Δerm spo0A mutant by transcriptional profiling. Scatter
plot of the log2 fold changes against the normalised mean read
abundance per gene (calculated at the base level). Red dots represent
genes considered to be significantly differentially expressed (P = ≤ 0.01).
Black dots signify genes not deemed to be significantly differentially
expressed according to these criteria.
Additional file 2: Table summarizing genes differentially expressed
in a C. difficile spo0A mutant relative to the parental strain based on
transcriptomics and proteomics. Datasets are presented in the context of
the entire updated reference genome annotation for C. difficile 630.
Additional file 3: Table summarizing gene regulation genes that
are controlled by C. difficile Spo0A.
Abbreviations
Spo0A: Stage 0 sporulation protein A; erm: Erythromycin resistance; RNAseq: RNA
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FDR: False discovery rate; TEM: Transmission electron microscopy.
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